Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market |
| |
| Authors: | Paul Corcoran Udo Reulbach Helen S Keeley Ivan J Perry Keith Hawton Ella Arensman |
| |
| Affiliation: | 1.National Suicide Research Foundation,Cork,Ireland;2.Department of Psychiatry,School of Medicine, University of Oviedo, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM),Oviedo,Spain;3.Department of Epidemiology and Public Health,University College,Cork,Ireland;4.Child and Adolescent Mental Health Services,North Cork Area, Health Service Executive South,Mallow,Ireland;5.Centre for Suicide Research, University of Oxford,Department of Psychiatry, Warneford Hospital,Headington,UK |
| |
| Abstract: | Background Distalgesic, the prescription-only analgesic compound of paracetamol (325 mg) and dextropropoxyphene (32.5 mg) known as co-proxamol in the UK, was withdrawn from the Irish market as of January 2006. This study aimed to evaluate the impact of the withdrawal of distalgesic in terms of intentional drug overdose (IDO) presentations to hospital emergency departments (EDs) nationally. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
